Recro Pharma, Inc. (REPH) analyst actions
Rating and price-target actions on REPH in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the REPH overview →
No REPH analyst action events in the measured window.
Nothing matched in the current window — the REPH overview has every event we measure for this name.
Get an email when REPH moves on news →Keep exploring
More REPH: earnings → · SEC filings → · REPH overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | 967 | +0.12% | 56% |
| QuidelOrtho Corporation (QDEL) | 965 | +0.02% | 50% |
| Athenex, Inc. (ATNX) | 964 | -0.43% | 41% |
| United Therapeutics Corporation (UTHR) | 964 | +0.03% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.